scholarly journals ISMP Adverse Drug Reactions: Adalimumab-Induced Aseptic Meningitis Pill Desiccant -Induced Acute Hypoxic Respiratory Failure Rivastigmine Patch -Induced Angioedema Acute Liver Failure Due to Etodolac Severe Cognitive Impairment Due to High Free Valproic Acid Levels

2018 ◽  
Vol 53 (5) ◽  
pp. 292-295
Author(s):  
Michael A. Mancano ◽  
Kristen J. Milenki ◽  
Morgan V. Esordi ◽  
Darshil D. Patel
Keyword(s):  
Valproic Acid ◽  
Cognitive Impairment ◽  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Safe Medication ◽  
Rivastigmine Patch ◽  
Temple University ◽  
The Us ◽  
Hypoxic Respiratory Failure ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of revention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-ßDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with ur readers. E-mail [email protected] ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

scholarly journals ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes

2019 ◽  
Vol 54 (4) ◽  
pp. 241-245
Author(s):  
Michael A. Mancano ◽  
Jonathan Lapin ◽  
Andrew Paik
Keyword(s):  
Adverse Drug Reactions ◽  
High Dose ◽  
Drug Reactions ◽  
High Dose Therapy ◽  
Safe Medication ◽  
Temple University ◽  
The Us ◽  
Amnestic Syndrome ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. E-mail Dr. Mancano at [email protected] . Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

scholarly journals ISMP Adverse Drug Reactions: Lithium-Induced Cardiomyopathy Fixed Drug Eruption Due to Cetirizine, Levocetirizine, and Hydroxyzine Nivolumab-Induced Myasthenia Gravis Nivolumab-Induced Cholangitic Liver Disease Torsade de Pointes Caused by Psychiatric Polypharmacy Trichotillomania Associated With Aripiprazole

2018 ◽  
Vol 53 (6) ◽  
pp. 371-375 ◽  
Author(s):  
Michael A. Mancano ◽  
Jacqueline Emily Von Bulow ◽  
Myungsun Ro
Keyword(s):  
Adverse Drug Reactions ◽  
Drug Eruption ◽  
Torsade De Pointes ◽  
Drug Reactions ◽  
Fixed Drug Eruption ◽  
Safe Medication ◽  
Temple University ◽  
The Us ◽  
Fixed Drug ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. E-mail Dr. Mancano [email protected] ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

scholarly journals ISMP Adverse Drug Reactions: Longitudinal Thumbnail Fissures Due to Erlotinib Priapism Associated With the Use of ExtenZe Blindness From a Nevirapine-Based HAART Regimen Hyperprolactinemia and Galactorrhea Due to Aripiprazole Trypophobia Associated With Gabapentin Coadministered Linezolid and Methadone Cause Serotonin Syndrome

2019 ◽  
Vol 54 (2) ◽  
pp. 88-92 ◽  
Author(s):  
Michael A. Mancano ◽  
Morgan V. Esordi ◽  
Darshil D. Patel ◽  
Kristen J. Milenki
Keyword(s):  
Adverse Drug Reactions ◽  
Serotonin Syndrome ◽  
Drug Reactions ◽  
Safe Medication ◽  
Temple University ◽  
The Us ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. E-mail Dr. Mancano at [email protected]. Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

scholarly journals ISMP Adverse Drug Reactions: Influenza Vaccine–Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption

2017 ◽  
Vol 53 (1) ◽  
pp. 15-17 ◽  
Author(s):  
Michael A. Mancano
Keyword(s):  
Influenza Vaccine ◽  
Skin Eruption ◽  
Adverse Drug Reactions ◽  
Stevens Johnson Syndrome ◽  
Drug Reactions ◽  
Safe Medication ◽  
Temple University ◽  
Johnson Syndrome ◽  
The Us ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: [email protected] ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Carbamazepine-Induced Pancreatitis; Quinolone-Induced Hypoglycemia; First Exposure Idarubicin and Cardiac Toxicity; Bupropion-Induced Sleepwalking; Nephrotic Syndrome Associated with Certolizumab Pegol; Extrapyramidal Effects and Suicidal Ideation with Fluoxetine

2010 ◽  
Vol 45 (4) ◽  
pp. 288-292
Author(s):  
Joel Shuster
Keyword(s):  
Nephrotic Syndrome ◽  
Suicidal Ideation ◽  
Cardiac Toxicity ◽  
Certolizumab Pegol ◽  
Drug Reactions ◽  
Safe Medication ◽  
Temple University ◽  
The Us ◽  
Extrapyramidal Effects ◽  
E Mail

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Shuster at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-947-7797; fax: 215-914-1492; e-mail: [email protected] ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Tendon Rupture with Statin Therapy; Sulfasalazine-Induced Immune Thrombocytopenia; Hyperammonemia with Valproic Acid; Cetuximab and Radiation Lead to Severe Cutaneous Reaction; Yet Another Skin Reaction Due to Monoclonal Antibodies; Manic Switching in Patients Receiving Duloxetine; Hyperprolactinemia and Galactorrhea Induced by SNRIs

2007 ◽  
Vol 42 (10) ◽  
pp. 893-896
Author(s):  
Joel Shuster
Keyword(s):  
Valproic Acid ◽  
Monoclonal Antibodies ◽  
Statin Therapy ◽  
Immune Thrombocytopenia ◽  
Tendon Rupture ◽  
Drug Reactions ◽  
Safe Medication ◽  
Temple University ◽  
E Mail ◽  
Severe Cutaneous Reaction

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers. Write to Dr. Shuster at ISMP, 1800 Byberry Road, Suite 810, Huntingdon Valley, PA 19006 (call 215-947-7797; fax 215-914-1492; e-mail: [email protected] ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices in cooperation with the FDA's medWatch Program and Temple University School of Pharmacy. ISMP is an FDA medWatch partner.

scholarly journals Acute Disseminated Intravascular Coagulation Due to Oxaliplatin; Azithromycin-Induced Stevens-Johnson Syndrome; Acute Jugular Vein Thrombosis with Rituximab; Hemorrhagic Bullae of the Fingers Induced by Furosemide

2017 ◽  
Vol 52 (1) ◽  
pp. 13-16
Author(s):  
Michael A. Mancano
Keyword(s):  
Jugular Vein ◽  
Stevens Johnson Syndrome ◽  
Drug Reactions ◽  
Jugular Vein Thrombosis ◽  
Safe Medication ◽  
Vein Thrombosis ◽  
Temple University ◽  
Johnson Syndrome ◽  
The Us ◽  
Hemorrhagic Bullae

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

scholarly journals Rivaroxaban-Induced DRESS; Serotonin Syndrome Induced by Paliperidone; Piperacillin-Tazobactam–Induced Nephritis and Hepatitis; Brentuximab-Induced Hand-Foot Syndrome; Valproic Acid–Induced Hyperkalemia

2017 ◽  
Vol 52 (2) ◽  
pp. 94-97
Author(s):  
Michael A. Mancano
Keyword(s):  
Valproic Acid ◽  
Adverse Drug Reactions ◽  
Serotonin Syndrome ◽  
Drug Reactions ◽  
The Us ◽  
Hand Foot Syndrome

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.

scholarly journals A Real-World, Multicenter Assessment of Drugs Requiring Weight-Based Calculations in Overweight, Adult Critically Ill Patients

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Sandra L. Kane-Gill ◽  
Nicholas P. Wytiaz ◽  
Lisa M. Thompson ◽  
Karina Muzykovsky ◽  
Mitchell S. Buckley ◽  
...  
Keyword(s):  
High Risk ◽  
Adverse Drug Reactions ◽  
Real World ◽  
Drug Reactions ◽  
Multicenter Observational Study ◽  
Increased Risk ◽  
The Us ◽  
Overweight Adult ◽  
Body Mass Indexes ◽  
Prospective Multicenter Observational Study

Prescribing appropriate doses of drugs requiring weight-based dosing is challenging in overweight patients due to a lack of data. With 68% of the US population considered overweight and these patients being at an increased risk for hospitalization, clinicians need guidance on dosing weight-based drugs. The purpose of this study was to identify “real-world” dose ranges of high-risk medications administered via continuous infusion requiring weight-based dosing and determine the reasons for dosing changes (ineffectiveness or adverse drug reactions). A prospective, multicenter, observational study was conducted in four intensive care units at three institutions. A total of 857 medication orders representing 11 different high-risk medications in 173 patients were reviewed. It was noted that dosing did not increase in proportion to weight classification. Overall, 14 adverse drug reactions occurred in nine patients with more in overweight patients (9 of 14). A total of 75% of orders were discontinued due to ineffectiveness in groups with higher body mass indexes. Ineffectiveness leads to dosing adjustments resulting in the opportunity for medication errors. Also, the frequent dosing changes further demonstrate our lack of knowledge of appropriate dosing for this population. Given the medications’ increased propensity to cause harm, institutions should aggressively monitor these medications in overweight patients.

Sign in / Sign up

Export Citation Format

Share Document